Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer

A Rossi, A La Salvia, M Di Maio - Expert Review of Respiratory …, 2017 - Taylor & Francis
Introduction: Preclinical data showed that intercalated administration of epidermal growth
factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy might be effective …
被引用次数：12 相关文章
[PDF] academia.edu

[PDF][PDF] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer

A Rossi, A La Salvia, M Di Maio - 2017 - academia.edu
Introduction: Preclinical data showed that intercalated administration of epidermal growth
factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy might be effective …

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer

A Rossi, A La Salvia, M Di Maio - Expert review of …, 2017 - pubmed.ncbi.nlm.nih.gov
Preclinical data showed that intercalated administration of epidermal growth factor receptor-
tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy might be effective in the treatment …

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer

A Rossi, A La Salvia, M Di Maio - EXPERT REVIEW OF …, 2017 - iris.unito.it
Preclinical data showed that intercalated administration of epidermal growth factor receptor-
tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy might be effective in the treatment …

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer.

A Rossi, A La Salvia, M Di Maio - Expert Review of Respiratory …, 2017 - europepmc.org
Preclinical data showed that intercalated administration of epidermal growth factor receptor-
tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy might be effective in the treatment …